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Background: Intracellular sodium ([Na+]i) kinetics are involved in cardiac diseases including ischemia, heart failure,
and hypertrophy. Because [Na+]i plays a crucial role in modulating the electrical and contractile activity in the heart,
quantifying [Na+]i is of great interest. Using fluorescent microscopy with sodium-binding benzofuran isophthalate
(SBFI) is the most commonly used method for measuring [Na+]i. However, one limitation associated with this
technique is that the test cannot simultaneously evaluate the effects of several types or various concentrations of
compounds on [Na+]i. Moreover, there are few reports on the long-term effects of compounds on [Na
+]i in cultured
cells, although rapid changes in [Na+]i during a period of seconds or several minutes have been widely discussed.
Findings: We established a novel technique for quantifying [Na+]i in cultured neonatal rat cardiomyocytes attached
to a 96-well plate using a microplate reader in combination with SBFI and probenecid. We showed that probenecid
is indispensable for the accurate measurement because it prevents dye leakage from the cells. We further confirmed
the reliability of this system by quantifying the effects of ouabain, which is known to transiently alter [Na+]i. To
illustrate the utility of the new method, we also examined the chronic effects of aldosterone on [Na+]i in cultured
cardiomyocytes.
Conclusions: Our technique can rapidly measure [Na+]i with accuracy and sensitivity comparable to the traditional
microscopy based method. The results demonstrated that this 96-well plate based measurement has merits,
especially for screening test of compounds regulating [Na+]i, and is useful to elucidate the mechanisms and
consequences of altered [Na+]i handling in cardiomyocytes.
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Background
The sodium ion (Na+) is the main determinant of the
body fluid distribution, and transsarcolemmal Na+ gradi-
ent is a key regulator of the various intracellular ions
and metabolites. In the heart, the concentration of free
intracellular Na+ ([Na+]i) has been shown to increase in
the presence of cardiac diseases including ischemia,
heart failure, and hypertrophy [1-5]. Because [Na+]i is
important in modulating the electrical and contractile
activity, quantifying [Na+]i is of great interest. Therefore,
several techniques for measuring [Na+]i have been estab-
lished to clarify the mechanisms and consequences of
altered [Na+]i regulation, and the standard procedure
currently used for measuring [Na+]i in a single cell is a
fluorescent microscopy-based method [6-10]. Sodium-
binding benzofuran isophthalate (SBFI), the most widely
used Na+-sensitive fluorescent indicator provides spatial
and temporal resolution of [Na+]i with sufficient select-
ivity in the presence of physiological concentrations of
other ions [11]. The ratiometric measurement with SBFI
permits us to cancel out variable dye concentrations in
the cells and shares the same filter equipment used for
the Ca2+ indicator, Fura-2. Although the use of micros-
copy and ratio imaging in combination with SBFI has
some merits, including the fact that it requires a min-
imal number of cells, permits the discrimination against
dye leaked out of the cells, and provides the ability to
see indicator compartmentalization [6], this technique
requires a fluorescence microscope equipment to switch
between filters. Furthermore, it is difficult to test the
effects of several types of compounds and/or compounds
at several concentrations simultaneously. On the other
hand, a method using a cell suspension loaded with
fluorescent indicator in a cuvette recorded by a spec-
trophotometer has been reported, but it might not be
adequate for living adherent cells. Moreover, when one
measures [Na+]i in cells using a closed culture space
without a perfusion chamber system to wash out the dye
leaked from the cells, this leaked dye reduces the accur-
acy of the measurements of [Na+]i [6].
Microplate readers with a 96-well format have been
widely used in combination with various types of cell-
based applications, including measuring the fluorescence
intensity, because it employs a standardized rapid proto-
col for screening and examining multiple cell types and
compounds, while requiring small amounts of materials.
A method for measuring [Ca2+]i in adherent cells at-
tached to a 96-well microtiter plate using a microplate
reader has been reported previously [12]. However, to
our knowledge, no microplate reader-based method has
previously been applied to measure [Na+]i in cardiomyo-
cytes in combination with SBFI. Moreover, there are few
reports on the long-term effects of compounds on [Na+]iin cultured cells, although rapid changes in [Na+]i during
a period of seconds or several minutes have been widely
discussed. In comparison with adult cardiomyocytes, neo-
natal cells have the advantage of being easily cultured and
having a longer viability. Therefore, we applied cultured
neonatal rat ventricular cardiomyocytes (NRVM) in this
system to examine the chronic effects of compounds on
[Na+]i.
The aim of this study was to investigate a new method
to measure [Na+]i in NRVM attached to a 96-well mi-
crotiter plate using a microplate reader and to confirm
the rational in vivo calibration method for SBFI in this
system. We also investigated the effects of probenecid
against dye leakage out of the cells. To confirm the reli-
ability of this technique, the rapid effects of the Na+/K+
ATPase inhibitor, ouabain, on [Na+]i were evaluated. We
further examined the chronic effects of aldosterone
on [Na+]i in NRVM to illustrate the utility of the new
method.
Results and discussion
Probenecid prevents the leakage of SBFI from
cardiomyocytes
As SBFI-AM hydrolyzes, the 340/380 nm excitation ratio
gradually increases [6]. In our preliminary experiment, the
fluorescence intensity continued to gradually increase dur-
ing the measurements, even after the 60-minute period
that had been previously reported to allow for complete
hydrolysis [6]. Di Virgilio, et al. reported that the conse-
quences of dye (Fura-2) leakage were relevant for experi-
ments in closed cuvettes, because secreted dye can
account for a considerable percentage of the total fluores-
cence signal [13-15]. Because each well of the 96-well plate
that we used in our experiment was also a closed space,
the gradual increase of fluorescence intensity after record-
ing for a 60-minute period, at which time the completion
of hydrolysis was expected [6], was speculated to be the
result of dye leakage. Probenecid, an organic anion trans-
port blocker, has been reported to prevent Fura-2 leakage
from cells, and this effect has also been reported for SBFI
used to measure [Na+]i [16]. Cao, et al. reported the value
of [Na+]i in neocortical neurons, and demonstrated that
several compounds induced changes in [Na+]i using a mi-
croplate reader with a 96-well format [17]. However, they
did not use probenecid in their experiments. They might
have been able to successfully measure [Na+]i in neocor-
tical neurons without taking into account the dye leakage,
because the significance of dye leakage from the cells
depends on the cell line.
To determine whether probenecid prevents dye leakage
from cardiomyocytes in our 96-well microplate-based
experiment, we compared the fluorescence ratio of SBFI
in the cells incubated with the recording medium in the

























































































Figure 1 (See legend on next page.)
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Figure 1 Probenecid inhibits SBFI leakage from neonatal rat cardiomyocytes. Adherent cardiomyocytes on a 96-well microplate were
loaded with 5 μM SBFI-AM for 90 min at room temperature. Cells were washed twice and incubated in Tyrode solution in the presence or absence of
1 mM probenecid. The fluorescence intensity was measured every 5 min. (A) The time course of the background-subtracted SBFI fluorescence intensity
at 340 nm (F340). (B) The time course of the background-subtracted SBFI fluorescence intensity at 380 nm (F380). (C) The relative SBFI fluorescence ratio
(F340/F380), with the ratio at 80 min in each group considered to be 100%. Solid lines, without probenecid; dashed lines, with probenecid. *P < 0.05 vs
cells treated without probenecid. The data are the means ± SE from four experiments.
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mately 80 min of recording with 1 mM probenecid in the
preliminary experiment, the relative fluorescence ratio com-
pared to that at 80 min was estimated. Figures 1A and 1B
clearly show the inhibitory effect of probenecid on the dye
leakage from cardiomyocytes. A stable fluorescence ratio was
obtained for at least 30 min after 80 min of recording in the
presence of probenecid, while the ratio continued to increase
in the wells without probenecid (solid line in Figure 1C. At
120 min recording, there was an estimated 8% increase in
the SBFI ratio, indicating an approximately 8–10 mM
increase in [Na+]i). This result indicates that probenecid is
essential to prevent the overestimation of [Na+]i caused by
dye leakage. The concentrations of probenecid and time
needed for treatment to inhibit dye leakage vary among dif-
ferent types of cells [13-15]. For our present method, pro-
benecid effectively blocked SBFI efflux at a concentration of
1 mM, and was added only during the recording period after
SBFI had been loaded into the cells. Therefore, in further ex-
periments, we measured [Na+]i in NRVM in Tyrode solution
in the presence of 1 mM of probenecid. Several reports have
suggested that probenecid can lead to unwanted effects in
cells. In particular, probenecid has been reported to reduce
the rise in [Ca2+]i induced by depolarization of the plasma
membrane or by a receptor-directed agonist, such as brady-
kinin [14]. Although this may not affect [Na+]i itself, atten-
tion is needed for the function of cells when using this agent
for a long time.
Measurement of [Na+]i and intracellular SBFI calibration in
NRVM
Figure 2 shows a typical in vivo calibration experiment
for SBFI in NRVM. Between 0 and 20 mM [Na+]i, the
SBFI fluorescence ratio (340/380 nm) showed a linear
relationship with [Na+]i (coefficient correlation (R
2) of
0.995, with a slope of 0.14 ratio units per 10 mM change
in [Na+]i). The value of [Na
+]i in NRVM calculated using
this method was 7.5 ± 0.4 mM (n = 24), which is similar to
the value in neonatal cardiomyocytes [18,19] and adult
cells [9,20-22] measured by microscopy or a spectropho-
tometer, which ranged from 5 to 13 mM. These results
suggest that our method has sensitivity comparable to the
microscopy-based method. The value of [Na+]i in myo-
cytes depends on the ionic strength, pH, and the compos-
ition of the solutions used during the isolation of the
myocytes [6,23,24]. In addition, the [Na+]i levels in freshlyprepared and cultured cells have been reported to be dif-
ferent for other cell lines [25]. Therefore, the protocol
used needs to be carefully understood to ensure that an
accurate comparison can be made of the absolute value of
[Na+]i. Dye compartmentalization has been reported when
SBFI is loaded at physiological temperature (37°C). How-
ever, this could be reduced by loading SBFI at room
temperature [26,27]. In fact, the fraction of SBFI compart-
mentalized has been reported to range from 10 to 50%
[7,8,10], and it is still uncertain even when it is recorded by
microscopy, because the loaded dye concentration and
loading time have varied among experiments. The disad-
vantages associated with population-averaged protocols
using a plate reader and multiple cells, which thus meant
that we could not directly detect indicator compart-
mentalization in the cells in each experiment are consid-
ered to be negligible, due to the fact that the changes in the
fluorescence ratio are considered to mainly reflect the
changes in the cytoplasmic [Na+] levels [6-8].
Transient effects of ouabain on [Na+]i in cardiomyocytes
Ouabain is a specific Na+/K+ pump inhibitor that has been
widely used for the treatment of patients with heart failure
and atrial fibrillation. Ouabain is known to transiently alter
[Na+]i in cardiomyocytes. To confirm the reliability of our
technique, we examined the effects of ouabain at con-
centrations of 100 μM and 200 μM on [Na+]i in NRVM.
During the application of ouabain, [Na+]i increased sig-
nificantly in a dose-dependent manner (Figure 3). The
mean value of [Na+]i at 20 min in the cells treated with
vehicle, 100 μM and 200 μM ouabain was 9.0 ± 0.4 mM,
11.4 ± 0.6 mM and 15.2 ± 1.0 mM, respectively (n = 13).
This result is comparable to the results reported using
ouabain or another specific Na+/K+ pump inhibitor,
strophanthidin, which were measured by fluorescent
microscopy or a spectrophotometer [7,9,19], suggesting
that our present technique detects the changes in [Na+]i
induced by agents with accuracy comparable to the
traditional microscopy-based method.
The long-term effects of aldosterone on [Na+]i in
cardiomyocytes
We and others have recently reported that aldosterone
induces [Na+]i elevation in cultured cardiomyocytes, and
that this effect was rapid, non-genomic, and occurred in





























Figure 2 In vivo calibration of SBFI. The in vivo calibration of SBFI was accomplished by exposing the myocytes to various extracellular [Na+].
Between 0 and 20 mM [Na+]i, the SBFI fluorescence ratio (F340/F380) showed a linear relationship with [Na
+]i (coefficient correlation (R
2) = 0.995, P= 0.0001).
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vated Na+/H+ exchange in cardiomyocytes [30], the long-
term effect of aldosterone on the estimated value of [Na+]i
in cardiomyocytes is still unknown. To clarify this, we mea-
sured [Na+]i in NRVM after treatment with vehicle or al-
dosterone at a concentration of 0.1 nM to 100 nM for 24 h
using the new method. The mean value of [Na+]i in cells
treated with 100 nM aldosterone was significantly higher
than that of cells treated with vehicle (9.1 ± 0.5 mM vs 6.7
± 0.4 mM, n = 11, P < 0.01), although a lower concentration
of aldosterone did not affect [Na+]i (Figure 4). This result
indicates that chronic aldosterone exposure alters [Na+]i
handling in cardiomyocytes, which might have (patho)





















Figure 3 Effects of ouabain on [Na+]i in cardiomyocytes. The time-depe
100 μM ouabain (open square) and 200 μM ouabain (open triangle). The data a
100 μM ouabain. The arrow indicates the application of compounds.Most of the previous studies about [Na+]i in the heart
were focused on the rapid effects of agents. However,
altered [Na+]i handling under pathological conditions,
including heart failure and cardiac hypertrophy, is a con-
tinuous phenomenon. In this context, using NRVM and
investigating the change in [Na+]i after long-term treat-
ment with various compounds may be helpful for under-
standing the mechanisms and consequences of [Na+]i
handling in the heart.
Conclusions
The results of this study indicate that using a microplate
reader and a ratiometric measurement of SBFI used in
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Figure 4 The long-term effects of aldosterone on [Na+]i in cardiomyocytes. Cardiomyocytes were treated with vehicle or aldosterone at a
concentration of 0.1 nM to 100 nM for 24 h. The data are the means ± SE from 11 experiments. *P < 0.01 vs vehicle.
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method has merits in that it allows for the changes in
[Na+]i in cultured cells treated with several types or con-
centration of agents to be measured simultaneously, and
provides a more thorough investigation of the long-term
effects of agents. In addition, the present method can be
applied to measure [Na+]i in other types of adherent
cells with some modification of the concentration of
probenecid and length of treatment.
Methods
Preparation of cardiomyocytes and cell culture
All animal procedures conformed to the National Insti-
tutes of Health Guide for the Care and Use of Laboratory
Animals and were approved by the Animal Research
Committee of Jikei University. NRVM were isolated from
one- to three-day-old Sprague–Dawley rats according to
the manufacturer’s protocol from Worthington Biochem-
ical (Lakewood, NJ). Purified NRVM were plated at a
density of 1*105 cells/well in 96 well clear bottom plates in
low-glucose (1000 mg/liter) DMEM (GIBCO) supple-
mented with 10% fetal bovine serum (GIBCO), 20 mM
HEPES and antibiotics (100 U/ml penicillin G and 100 μg/
ml streptomycin; Wako). The cells were allowed to attach
at 37°C in a 5% CO2 atmosphere, and subconfluent myo-
cyte monolayers were obtained after 48 h. Sixteen hours
before treatments with the indicated agents, the medium
was replaced with DMEM supplemented with charcoal-
stripped FBS (GIBCO).
Measurement of [Na+]i in NRVM
NRVM were loaded with 5 μM SBFI-acetoxymethylester
(AM) (Molecular Probes) dissolved in Tyrode solution
(mM): 150 NaCl, 5.4 KCl, 1.2 MgCl2, 0.4 NaH2PO4, 10
HEPES, 5 glucose, and 1 CaCl2 (pH 7.4) for 90 min at
room temperature in the presence of the non-ionicsurfactant, Pluronic F-127 (0.05% w/v) [9,20]. After
washing out the external dye twice with Tyrode solution,
leaving a final volume of 200 μl in each well, the fluores-
cence intensity was measured by an Infinite 200 PRO
microplate reader (TECAN) at room temperature. Dual
excitation measurements at 340 nm and 380 nm were
performed, and the emitted fluorescence was recorded
at 510 ± 12.5 nm by the fluorescence bottom reading
mode. The completion of hydrolysis was judged by
attainment of a stable 340/380 nm ratio. In the experi-
ments using ouabain, after attainment of a stable fluor-
escence ratio, we replaced 50 μl of medium in each well
with 50 μl of a ouabain-containing solution. The micro-
plate reader can take measurements in each well of a
plate within 90 seconds, and the fluorescence intensity
was automatically recorded every 2.5-5 minutes. In each
microplate, NRVM of the same preparation in 10 wells
were prepared with Tyrode solution in the absence of
SBFI to measure the background signals of NRVM and
microplates. Mean fluorescence signals from the 10 SBFI-
unloaded wells at 340 nm and 380 nm were subtracted
from the individual signals of SBFI-loaded wells at each
wavelength. All of the experimental conditions, including
in vivo calibrations, were performed in sextuplicate.
In vivo calibration of SBFI
The in vivo calibration of SBFI was accomplished, similar
to the previous reports, by exposing the cardiomyocytes to
various concentrations of extracellular [Na+] (0–20 mM)
in the presence of 1 mg/l gramicidin D, 100 μM stro-
phanthidin, 2 mM EGTA, and the pH was adjusted to 7.1
with Tris base [9,20]. Myocytes had been treated with
gramicidin D to allow the free movement of Na+, K+, and
H+, strophanthidin to inhibit the Na+/K+ pump, and
EGTA to increase the permeability of the cell membrane
to Na+ [6,8,9]. Using these agents, a stable equilibrium
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achieved. A linear fit of the calibration plots between 0
and 20 mM [Na+]i was used to convert SBFI fluorescence
ratios (340/380 nm) to values of [Na+]i. The calibration so-
lutions were prepared by mixing two solutions of equal
ionic strength. One solution contained 145 mM Na+
(30 mM NaCl, 115 mM sodium gluconate) and no K+,
while the other one had 145 mM K+ (30 mM KCl,
115 mM potassium gluconate) and no Na+. Under these
calibration conditions, the effect of K+ on SBFI is neg-
ligible in physiological [Na+]i between 0 and 20 mM,
although SBFI is known to be sensitive to K+ [9]. A cali-
bration was performed at the end of each experiment.
Statistical analyses
The data are expressed as the means ± standard error for
the indicated number of experiments. The statistical
analyses were performed using Student’s t test and one
way ANOVA, followed by Scheffe's test. Values of P < 0.05
were considered to be significant.
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